Cognitive profile in BECTS treated with levetiracetam: A 2-year follow-up

Michele Roccella, Lucia Margari, Roberta Mazza, Grazia Maria Giovanna Pastorino, Francesca Felicia Operto, Marco Carotenuto, Alberto Verrotti, Maria Rosalia Carotenuto

Risultato della ricerca: Article

2 Citazioni (Scopus)

Abstract

Introduction: Benign epilepsy with centrotemporal spikes (BECTS) is a common epileptic syndrome in childhood, characterized by brief and infrequent partial motor seizures, with or without generalization and mostly recurring during sleep. Because of its favorable efficacy, tolerability, and safety profile, levetiracetam (LEV) monotherapy is often administered in these patients. Long-term effects of LEV therapy and its influence on cognitive functions remain controversial.Purpose: This evaluated the changes in the cognitive profile of children with BECTS treated with LEV monotherapy for 2 years, compared with a control group of children with specific learning disabilities.Method: Our patient cohort included 20 children aged 8-14 years diagnosed as having BECTS and administered LEV monotherapy and 10 age/sex-matched controls with specific learning disabilities. All participants underwent a standardized test for assessing cognitive profile (Wechsler Intelligence Scale for Children - Fourth Edition [WISC-IV]) before drug therapy and after 2 years of treatment. Average LEV blood level and electroencephalo-graphic (EEG) recordings were periodically monitored. Several factors such as age, sex, response to therapy, and EEG pattern changes were considered. Statistical analysis was performed using Student's t-test for paired and independent samples. p < 0.05 was considered statistically significant.Results: Children administered LEV for 24 months showed a mild but statistically significant improvement in overall cognitive abilities. Verbal skills, visual-perceptual reasoning, working memory, and processing speed showed slight but significant improvement. In the control group, cognitive profile remained substantially unchanged at 2-year follow-up.Conclusions: Not only do our data suggest a nonworsening of the cognitive profile in BECTS with LEV but, on the contrary, cognitive scores also improved over time, unlike the control group. (C) 2019 Elsevier Inc. All rights reserved.
Lingua originaleEnglish
pagine (da-a)187-191
Numero di pagine5
RivistaEPILEPSY & BEHAVIOR
Volume97
Stato di pubblicazionePublished - 2019

Fingerprint

etiracetam
Rolandic Epilepsy
varespladib methyl
Learning Disorders
Control Groups
Wechsler Scales
Aptitude
Intelligence
Short-Term Memory
Cognition

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology
  • Behavioral Neuroscience

Cita questo

Roccella, M., Margari, L., Mazza, R., Pastorino, G. M. G., Operto, F. F., Carotenuto, M., ... Carotenuto, M. R. (2019). Cognitive profile in BECTS treated with levetiracetam: A 2-year follow-up. EPILEPSY & BEHAVIOR, 97, 187-191.

Cognitive profile in BECTS treated with levetiracetam: A 2-year follow-up. / Roccella, Michele; Margari, Lucia; Mazza, Roberta; Pastorino, Grazia Maria Giovanna; Operto, Francesca Felicia; Carotenuto, Marco; Verrotti, Alberto; Carotenuto, Maria Rosalia.

In: EPILEPSY & BEHAVIOR, Vol. 97, 2019, pag. 187-191.

Risultato della ricerca: Article

Roccella, M, Margari, L, Mazza, R, Pastorino, GMG, Operto, FF, Carotenuto, M, Verrotti, A & Carotenuto, MR 2019, 'Cognitive profile in BECTS treated with levetiracetam: A 2-year follow-up', EPILEPSY & BEHAVIOR, vol. 97, pagg. 187-191.
Roccella M, Margari L, Mazza R, Pastorino GMG, Operto FF, Carotenuto M e altri. Cognitive profile in BECTS treated with levetiracetam: A 2-year follow-up. EPILEPSY & BEHAVIOR. 2019;97:187-191.
Roccella, Michele ; Margari, Lucia ; Mazza, Roberta ; Pastorino, Grazia Maria Giovanna ; Operto, Francesca Felicia ; Carotenuto, Marco ; Verrotti, Alberto ; Carotenuto, Maria Rosalia. / Cognitive profile in BECTS treated with levetiracetam: A 2-year follow-up. In: EPILEPSY & BEHAVIOR. 2019 ; Vol. 97. pagg. 187-191.
@article{e18df350faf04bcfb3d8713b88de943e,
title = "Cognitive profile in BECTS treated with levetiracetam: A 2-year follow-up",
abstract = "Introduction: Benign epilepsy with centrotemporal spikes (BECTS) is a common epileptic syndrome in childhood, characterized by brief and infrequent partial motor seizures, with or without generalization and mostly recurring during sleep. Because of its favorable efficacy, tolerability, and safety profile, levetiracetam (LEV) monotherapy is often administered in these patients. Long-term effects of LEV therapy and its influence on cognitive functions remain controversial.Purpose: This evaluated the changes in the cognitive profile of children with BECTS treated with LEV monotherapy for 2 years, compared with a control group of children with specific learning disabilities.Method: Our patient cohort included 20 children aged 8-14 years diagnosed as having BECTS and administered LEV monotherapy and 10 age/sex-matched controls with specific learning disabilities. All participants underwent a standardized test for assessing cognitive profile (Wechsler Intelligence Scale for Children - Fourth Edition [WISC-IV]) before drug therapy and after 2 years of treatment. Average LEV blood level and electroencephalo-graphic (EEG) recordings were periodically monitored. Several factors such as age, sex, response to therapy, and EEG pattern changes were considered. Statistical analysis was performed using Student's t-test for paired and independent samples. p < 0.05 was considered statistically significant.Results: Children administered LEV for 24 months showed a mild but statistically significant improvement in overall cognitive abilities. Verbal skills, visual-perceptual reasoning, working memory, and processing speed showed slight but significant improvement. In the control group, cognitive profile remained substantially unchanged at 2-year follow-up.Conclusions: Not only do our data suggest a nonworsening of the cognitive profile in BECTS with LEV but, on the contrary, cognitive scores also improved over time, unlike the control group. (C) 2019 Elsevier Inc. All rights reserved.",
author = "Michele Roccella and Lucia Margari and Roberta Mazza and Pastorino, {Grazia Maria Giovanna} and Operto, {Francesca Felicia} and Marco Carotenuto and Alberto Verrotti and Carotenuto, {Maria Rosalia}",
year = "2019",
language = "English",
volume = "97",
pages = "187--191",
journal = "EPILEPSY &amp; BEHAVIOR",
issn = "1525-5050",

}

TY - JOUR

T1 - Cognitive profile in BECTS treated with levetiracetam: A 2-year follow-up

AU - Roccella, Michele

AU - Margari, Lucia

AU - Mazza, Roberta

AU - Pastorino, Grazia Maria Giovanna

AU - Operto, Francesca Felicia

AU - Carotenuto, Marco

AU - Verrotti, Alberto

AU - Carotenuto, Maria Rosalia

PY - 2019

Y1 - 2019

N2 - Introduction: Benign epilepsy with centrotemporal spikes (BECTS) is a common epileptic syndrome in childhood, characterized by brief and infrequent partial motor seizures, with or without generalization and mostly recurring during sleep. Because of its favorable efficacy, tolerability, and safety profile, levetiracetam (LEV) monotherapy is often administered in these patients. Long-term effects of LEV therapy and its influence on cognitive functions remain controversial.Purpose: This evaluated the changes in the cognitive profile of children with BECTS treated with LEV monotherapy for 2 years, compared with a control group of children with specific learning disabilities.Method: Our patient cohort included 20 children aged 8-14 years diagnosed as having BECTS and administered LEV monotherapy and 10 age/sex-matched controls with specific learning disabilities. All participants underwent a standardized test for assessing cognitive profile (Wechsler Intelligence Scale for Children - Fourth Edition [WISC-IV]) before drug therapy and after 2 years of treatment. Average LEV blood level and electroencephalo-graphic (EEG) recordings were periodically monitored. Several factors such as age, sex, response to therapy, and EEG pattern changes were considered. Statistical analysis was performed using Student's t-test for paired and independent samples. p < 0.05 was considered statistically significant.Results: Children administered LEV for 24 months showed a mild but statistically significant improvement in overall cognitive abilities. Verbal skills, visual-perceptual reasoning, working memory, and processing speed showed slight but significant improvement. In the control group, cognitive profile remained substantially unchanged at 2-year follow-up.Conclusions: Not only do our data suggest a nonworsening of the cognitive profile in BECTS with LEV but, on the contrary, cognitive scores also improved over time, unlike the control group. (C) 2019 Elsevier Inc. All rights reserved.

AB - Introduction: Benign epilepsy with centrotemporal spikes (BECTS) is a common epileptic syndrome in childhood, characterized by brief and infrequent partial motor seizures, with or without generalization and mostly recurring during sleep. Because of its favorable efficacy, tolerability, and safety profile, levetiracetam (LEV) monotherapy is often administered in these patients. Long-term effects of LEV therapy and its influence on cognitive functions remain controversial.Purpose: This evaluated the changes in the cognitive profile of children with BECTS treated with LEV monotherapy for 2 years, compared with a control group of children with specific learning disabilities.Method: Our patient cohort included 20 children aged 8-14 years diagnosed as having BECTS and administered LEV monotherapy and 10 age/sex-matched controls with specific learning disabilities. All participants underwent a standardized test for assessing cognitive profile (Wechsler Intelligence Scale for Children - Fourth Edition [WISC-IV]) before drug therapy and after 2 years of treatment. Average LEV blood level and electroencephalo-graphic (EEG) recordings were periodically monitored. Several factors such as age, sex, response to therapy, and EEG pattern changes were considered. Statistical analysis was performed using Student's t-test for paired and independent samples. p < 0.05 was considered statistically significant.Results: Children administered LEV for 24 months showed a mild but statistically significant improvement in overall cognitive abilities. Verbal skills, visual-perceptual reasoning, working memory, and processing speed showed slight but significant improvement. In the control group, cognitive profile remained substantially unchanged at 2-year follow-up.Conclusions: Not only do our data suggest a nonworsening of the cognitive profile in BECTS with LEV but, on the contrary, cognitive scores also improved over time, unlike the control group. (C) 2019 Elsevier Inc. All rights reserved.

UR - http://hdl.handle.net/10447/375171

UR - http://www.elsevier.com/inca/publications/store/6/2/2/8/2/2/index.htt

M3 - Article

VL - 97

SP - 187

EP - 191

JO - EPILEPSY &amp; BEHAVIOR

JF - EPILEPSY &amp; BEHAVIOR

SN - 1525-5050

ER -